| |
|
|
|
Aerpio Pharmaceuticals Inc.  
|
|
1.9 -0.09 (-0.05%) |
11-20 14:01 |
|
Open: |
1.91 |
Pre close: |
1.99 |
Target:
|
2.59 
|
|
High: |
1.98 |
Low: |
1.86 |
Resistance:
|
2.22
2.45
|
|
Volume: |
41,194 |
Market Cap: |
77M |
Support:
|
1.85
1.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.96
|
MACD |
MACD(12,26):
|
-0.16  |
|
MA(20): |
2.01 |
Signal(12,26,9): |
-0.19 |
|
MA(100): |
3.20 |
Stochastic Oscillator |
%K(14,3):
|
21.23 |
|
MA(250): |
3.98 |
%D(3): |
23.51 |
|
Average Volume(K) |
3-Month: |
8533
|
52-Week |
High:
|
5.50 |
|
10-Days: |
7955 |
Low: |
1.85 |
|
RSI |
RSI(14):
|
37.88 |
Change(%): |
-61.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-18.0 |
Shares Out. (M) |
40.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.9 |
Shares Float (M) |
40.58 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.60 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.910 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.66 |
|
Profit Margin |
-40.25 |
Operating Cash Flow
(M) |
-4.24 |
P/S |
118212496.00 |
|
Operating Margin |
-42.69 |
Levered Free Cash Flow
(M) |
-3.97 |
P/CF |
-18.42 |
|
|
|
|
|
|
